Files

826843.pdf (939.3 KB)

Document type

Article

Version

Published version

Publication date

2022-09-01

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/218386

Genetic Study of Susceptibility of Atypical Femoral Fractures Related to Bisphosphonate Treatment

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1007/s40520-022-02147-3

Abstract

Proceedings of the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022) Atypical femoral fractures (AFF) are low-trauma fractures with increased risk under long-term bisphosphonate (BP) treatment

Subject

Fractures, Fèmur

Subject (English)

Fractures, Femur

Citation

Collections

Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Citation

GARCIA GIRALT, Natàlia, et al. Genetic Study of Susceptibility of Atypical Femoral Fractures Related to Bisphosphonate Treatment. Aging Clinical and Experimental Research. 2022. Vol. 34, num. SUPPL 1, pags. S249-S249. ISSN 1594-0667. [consulted: 18 of June of 2026]. Available at: https://hdl.handle.net/2445/218386

Export metadata

JSON - METS

Share record